The Wall Street Journal: Moderna prices IPO at $23 a share, raising over $600 million

Moderna Inc. staged one of the biggest initial public offerings for a biotechnology company late Thursday, a bright spot in an otherwise tumultuous market.

Moderna sold 26.3 million of its shares at $23 apiece Thursday, in line with pricing expectations on the eve of its trading debut. The offering’s size was bigger than expected, raising $604.3 million and valuing the company at roughly $7.5 billion.

Read: Moderna IPO: 5 things to know about potentially the largest U.S. biotech IPO in history

The listing is expected to be one of the last big IPOs in a year that has ushered in more than 200 new listings, raised more than $58 billion and is set to be the busiest since 2014. Pricing within range and increasing the offering bode well for the resiliency of the IPO market even as sharp stock swings have become more common.

The next test will be how Moderna’s shares trade. They are set to make their stock-market debut Friday on the Nasdaq Global Market under the stock symbol MRNA MRNA, +0.00%  .

An expanded version of this report appears on WSJ.com.

Also popular on WSJ.com:

Meng Wanzhou, Huawei CFO and founder’s daughter, has been face of secretive company.

In Latin America, awash in crime, citizens impose their own brutal justice.

Filed in: Top News Tags: 

You might like:

Capitol Report: Commerce Department report backing 25% tariffs on auto imports could hit Sunday Capitol Report: Commerce Department report backing 25% tariffs on auto imports could hit Sunday
Cannabis Watch: Cannabis company Aphria finds some board members had conflicts in Latam deal Cannabis Watch: Cannabis company Aphria finds some board members had conflicts in Latam deal
XPO Logistics stock plunges, as cut back by largest customer, weak Europe trump big buybacks XPO Logistics stock plunges, as cut back by largest customer, weak Europe trump big buybacks
Beset by recalls and falling meat prices, America’s biggest meat producer wants to take a bite out of the vegetarian market Beset by recalls and falling meat prices, America’s biggest meat producer wants to take a bite out of the vegetarian market
BookWatch: Here’s why the craft cannabis industry can thrive in the face of Big Marijuana BookWatch: Here’s why the craft cannabis industry can thrive in the face of Big Marijuana
The polar vortex probably won’t increase your January heating bills — here’s why The polar vortex probably won’t increase your January heating bills — here’s why
How much ginger is there in America’s best-selling ginger ale? How much ginger is there in America’s best-selling ginger ale?
Love & Money: Does your future husband or wife have financial problems? Here’s how to find out Love & Money: Does your future husband or wife have financial problems? Here’s how to find out

Leave a Reply

Submit Comment
© 2019 Stock Investors News. All rights reserved. XHTML / CSS Valid.